TREATMENT OF INFLAMMATORY DISEASES OF THE CENTRAL NERVOUS SYSTEM

摘要

The present invention relates to the use of flumazenil for the treatment of inflammatory conditions of the central nervous system, such as migraine, headache and multiple sclerosis, anxiety, PTSD, psychosis, depression, and cessation of addictive behaviours. The active may be administered in the form of an implant. The present invention also relates to the use of flumazenil, naltrexone, and optionally buprenorphine in order to reduce symptoms associated with withdrawal of drugs of dependence or addictive behaviours.